IRIS
PICCHIO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.989
EU - Europa 7.709
AS - Asia 6.565
SA - Sud America 1.695
Continente sconosciuto - Info sul continente non disponibili 476
AF - Africa 144
OC - Oceania 24
Totale 24.602
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.677
RU - Federazione Russa 3.762
SG - Singapore 2.288
CN - Cina 1.953
BR - Brasile 1.343
IT - Italia 974
SE - Svezia 834
HK - Hong Kong 792
VN - Vietnam 626
RO - Romania 536
BD - Bangladesh 362
ES - Italia 352
FR - Francia 331
DE - Germania 253
GB - Regno Unito 179
CA - Canada 150
FI - Finlandia 146
AR - Argentina 141
IN - India 117
MX - Messico 87
PL - Polonia 73
ID - Indonesia 65
EC - Ecuador 60
NL - Olanda 59
ZA - Sudafrica 57
TR - Turchia 51
IE - Irlanda 49
IQ - Iraq 45
JP - Giappone 43
AT - Austria 41
CO - Colombia 40
PY - Paraguay 28
MD - Moldavia 27
CL - Cile 24
PK - Pakistan 23
NP - Nepal 22
PE - Perù 22
AU - Australia 21
MY - Malesia 20
SA - Arabia Saudita 20
UA - Ucraina 20
VE - Venezuela 19
MA - Marocco 17
PH - Filippine 16
UZ - Uzbekistan 16
JO - Giordania 14
DZ - Algeria 13
IR - Iran 13
JM - Giamaica 13
KE - Kenya 13
CR - Costa Rica 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
LT - Lituania 11
AZ - Azerbaigian 10
BE - Belgio 10
IL - Israele 10
PT - Portogallo 10
TN - Tunisia 10
UY - Uruguay 10
CZ - Repubblica Ceca 8
HN - Honduras 8
BO - Bolivia 7
GT - Guatemala 7
RS - Serbia 7
EU - Europa 6
KZ - Kazakistan 6
TT - Trinidad e Tobago 6
AL - Albania 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
KR - Corea 5
OM - Oman 5
TW - Taiwan 5
CI - Costa d'Avorio 4
GR - Grecia 4
LB - Libano 4
NI - Nicaragua 4
PA - Panama 4
PS - Palestinian Territory 4
SN - Senegal 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BG - Bulgaria 3
CH - Svizzera 3
CY - Cipro 3
HU - Ungheria 3
KH - Cambogia 3
LV - Lettonia 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
AO - Angola 2
AW - Aruba 2
BZ - Belize 2
GD - Grenada 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 24.115
Salva come PNG Salva come JPEG
Città #
Dallas 3.113
Singapore 967
Moscow 799
Hong Kong 777
Ashburn 702
San Jose 606
Shanghai 375
Milan 334
Council Bluffs 319
Valencia 303
Hefei 299
New York 276
Beijing 274
Lauterbourg 251
Princeton 245
Lawrence 244
Ho Chi Minh City 206
Hanoi 151
Santa Clara 148
Los Angeles 127
São Paulo 116
Munich 100
Rome 78
Orem 77
Helsinki 73
Boardman 72
Turku 59
Brooklyn 53
Warsaw 49
Dublin 48
Chicago 44
Rio de Janeiro 39
Montreal 38
Buffalo 34
Chennai 34
Da Nang 34
Tokyo 34
Frankfurt am Main 33
Seattle 32
Denver 31
Johannesburg 31
Toronto 31
Atlanta 30
London 29
Manchester 29
Stockholm 29
Washington 29
Mexico City 28
Naples 28
The Dalles 28
Belo Horizonte 27
Poplar 27
Haiphong 25
Guangzhou 24
Nuremberg 24
Amsterdam 22
Phoenix 22
Quito 22
West Jordan 22
Ankara 21
Curitiba 21
Dhaka 21
Houston 21
Boston 20
Brasília 20
Las Vegas 18
Charlotte 17
Lima 17
Mumbai 17
Philadelphia 17
Shenzhen 17
Baghdad 16
Guayaquil 16
Vienna 16
Barnet 15
Columbus 15
Genoa 15
Ninh Bình 15
Tashkent 15
Turin 15
Buenos Aires 14
Can Tho 14
Guarulhos 14
Manaus 14
New Delhi 14
Asunción 13
Campinas 13
Porto Alegre 13
Amman 12
Goiânia 12
Hangzhou 12
Jakarta 12
Lappeenranta 12
Newark 12
San Francisco 12
Bari 11
Bexley 11
Biên Hòa 11
Bogotá 11
Brescia 11
Totale 12.714
Salva come PNG Salva come JPEG
Nome #
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 1.440
11C-choline PET/CT and PSA kinetics 1.397
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 279
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 198
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 197
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 194
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 189
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 188
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 187
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 182
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 173
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 168
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 163
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 161
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 152
18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers 151
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 150
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 147
Development of a new toolbox for mouse PET-CT brain image analysis fully based on CT images and validation in a PD mouse model 147
Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer 144
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 143
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM) 142
Data-Driven Motion Correction of 11C-Methionine PET Images on a Cohort of Pediatric Patients With Brain Tumor in a PET/MRI Study 138
18F-FDG uptake by prosthetic arterial grafts in large vessel vasculitis is not specific for active disease: results from a cohort study 138
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 136
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 133
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 133
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 132
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 132
[11C]CHOLINE PET/CT for Early Detection of Tumor in Prostate Cancer Patients with PSA Level Lower Than 1.5 NG/ML 130
18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry 130
Combined 68Ga-DOTA-peptides and 18F-FDG PET in the diagnostic work-up of neuroendocrine neoplasms (NEN) 129
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 128
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 127
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 127
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 127
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 125
18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis 125
18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience 124
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 124
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 122
18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma 122
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study 121
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 121
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 121
18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy 121
[F-18]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients 121
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients 119
18F-FDG PET/CT AND UROTHELIAL CARCINOMA: IMPACT ON MANAGEMENT AND PROGNOSIS—A MULTICENTER RETROSPECTIVE STUDY IN BOOK ROLE OF MEDICAL IMAGING IN CANCERS 118
Hypoxia pathway: 18F-FAZA 118
[11C]choline PET/CT for the detection of tumor recurrence in prostate cancer patients with PSA<1.5 ng/mL 118
Hypoxia PET imaging beyond 18F-FMISO in patients with high-grade glioma: 18F-FAZA and other hypoxia radiotracers 118
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort 115
[11C]CHOLINE PET/CT FOR RESTAGING PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY AND NO EVIDENCE OF DISEASE ON CONVENTIONAL IMAGING 115
11C-or18F-Choline PET/CT for imaging evaluation of biochemical recurrence of prostate cancer 115
State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review 115
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 114
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 114
PSMA PET in brain metastases: navigating diagnostic challenges– a thorough exploration 110
When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool 110
[C-11]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 109
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference 108
Diagnosis of local recurrence after radical prostatectomy 107
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 105
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 105
Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment 105
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 104
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 102
18F-FDG positron emission tomography compared with computed tomography in diagnosing recurrent ovarian carcinoma 100
Radiomics and artificial intelligence 99
The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer 99
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 99
18Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET)-Guided Target Delineation in Lung Cancer 98
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 97
CRITICAL ASSESSMENT OF THE PERFORMANCE OF PSA KINETICS FOR THE PREDICTION OF [11C]CHOLINE PET/CT IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 94
18F-FDG PET/CT AND UROTHELIAL CARCINOMA: IMPACT ON MANAGEMENT AND PROGNOSIS—A MULTICENTER RETROSPECTIVE STUDY 92
3D Spatial resolution proprieties of Molecubes β-Cube: Characterization with different isotopes 92
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 90
[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment 89
[C-11]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy 87
FDG Uptake by Prosthetic Arterial Grafts in Large Vessel Vasculitis Is Not Specific for Active Disease 85
Choline PET/CT features to predict survival outcome in high risk prostate cancer restaging: a preliminary machine-learning radiomics study 85
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study 84
18F-FDG PET/CT for Early Postradiotherapy Assessment in Solitary Bone Plasmacytomas 83
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers 82
Concomitant Lung Cancer and Gastrointestinal Stromal Tumor: First Report of Hypoxia Imaging With 18F-FAZA PET/CT 82
Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study 82
Combined Use of TBNA and EBUS-TBNA in the Preoperative Staging of Lung Cancer Patients 76
Imaging in evaluation of response to neo-adjuvant treatment 76
18FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (18FDG-PET)-GUIDED TARGET DELINEATION IN LUNG 75
Bone metastases are infrequent in patients with newly diagnosed prostate cancer: Analysis of their clinical and pathologic features 75
Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques 75
Increased Choline Uptake in Bronchioalveolar Cell Carcinoma with Negative FDG Uptake. A PET/CT and Pathology Study 75
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 75
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 74
Hypoxia and Amino Acid Imaging of High-Grade Glioma18F-FAZA PET/CT and 11C-Methionine PET/MRI 74
PET/MRI and prostate cancer 71
Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer 71
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms 70
VALIDAZIONE TRAMITE LINFOADENECTOMIA PELVICA E RETROPERITONEALE DELLA ACCURATEZZA DELLA TC/PET CON 11CCOLINA NELLA DIAGNOSI DI METASTASI LINFONODALI IN PAZIENTI CON RECIDIVA BIOCHIMICA DI CARCINOMA PROSTATICO DOPO PROSTATECTOMIA RADICALE 69
Totale 14.498
Salva come PNG Salva come JPEG
Categoria #
all - tutte 134.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.828
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022221 0 11 1 96 14 7 13 12 18 29 5 15
2022/20231.532 543 314 123 36 23 178 81 124 43 31 5 31
2023/20241.006 52 45 149 102 66 168 36 104 12 60 54 158
2024/20254.332 529 66 65 99 141 302 1.162 285 584 441 288 370
2025/202616.059 927 1.466 3.291 1.935 924 351 1.169 881 3.344 718 447 606
2026/20271.177 610 567 0 0 0 0 0 0 0 0 0 0
Totale 24.602